Optometrists in Bountiful, UT Accepting Medicare

11 Optometrists found. Showing 1 - 11

Dr. Robert Murray Wilkes, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 140 S Main St, Bountiful, UT 84010 Phone: 801-295-2020    Fax: 801-292-5575

Shopko Optical 107 Optometrist Medicare: Not Enrolled in Medicare Practice Location: 190 S 500 W, Bountiful, UT 84010 Phone: 801-295-9200

Dr. Adam Barry Rudd, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 70 N Main St, Bountiful, UT 84010 Phone: 801-292-1408    Fax: 801-292-1966

Duane Knowles, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 140 W 5th S, Bountiful, UT 84010 Phone: 801-292-0479    Fax: 801-292-7019

Bountiful Eye Care Pc Optometrist Medicare: Medicare Enrolled Practice Location: 140 S Main St, Bountiful, UT 84010 Phone: 801-295-2020    Fax: 801-292-8761

Shawn Page Murray, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 190 S 500 W, Bountiful, UT 84010 Phone: 801-295-9200    Fax: 801-292-9390

Dr. Daniel Wayne Pace, O.D Optometrist Medicare: Accepting Medicare Assignments Practice Location: 70 N Main St, Suite 102, Bountiful, UT 84010 Phone: 801-292-1408    Fax: 801-292-1966

Standard Optical Co Optometrist Medicare: Not Enrolled in Medicare Practice Location: 140 W 5th S, Bountiful, UT 84010 Phone: 801-292-0479    Fax: 801-292-7019

Douglas R Smith, O D Optometrist Medicare: Accepting Medicare Assignments Practice Location: 311 E 500 S, Bountiful, UT 84010 Phone: 801-295-4441    Fax: 801-294-5416

Family Vision Care Of Bountiful Optometrist Medicare: Medicare Enrolled Practice Location: 70 N Main St, Suite 102, Bountiful, UT 84010 Phone: 801-292-1408    Fax: 801-292-1966

Bountiful Vision Plaza Pc Optometrist Medicare: Medicare Enrolled Practice Location: 311 E 500 S, Bountiful, UT 84010 Phone: 801-295-4441    Fax: 801-294-5416

News Archive

Exosome Diagnostics closes Series B financing round with the raising of $27 million

Exosome Diagnostics today announced the initial close of its Series B financing round with the raising of $27 million. Proceeds will be used to advance development of the Company's proprietary platform technology and commercial programs for non-invasive, fluid-based molecular diagnostics in oncology, neurodegenerative diseases and other clinical areas.

New paper device could rapidly and inexpensively assess hepatitis B, male infertility

Scientists have developed a new paper device that analyzes DNA and could rapidly and inexpensively assess disparate conditions including hepatitis B and male infertility, which together affect millions of people around the world. The test, reported in the Journal of the American Chemical Society, could be of particular help diagnosing people in low-income areas.

Pre-operative education programme can reduce hospital stay for knee replacement patients

Potential to reduce NHS costs while offering more effective rehabilitation for knee replacement patients has been identified following a 20 month study carried out by academics at Northumbria University in conjunction with Gateshead Health NHS Foundation Trust.

Breakthrough discovery reveals brain metals that may drive progression of Alzheimer's disease

Alzheimer's disease could be better treated, thanks to a breakthrough discovery of the properties of the metals in the brain involved in the progression of the neurodegenerative condition, by an international research collaboration including the University of Warwick.

People with severe mental illness may have higher risk for substance use

People with severe mental illness such as schizophrenia or bipolar disorder have a higher risk for substance use, especially cigarette smoking, and protective factors usually associated with lower rates of substance use do not exist in severe mental illness, according to a new study funded by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health.

Read more Medical News

› Verified 5 days ago